India welcomes US decision to back IP rules waiver for Covid-19 vaccines

For the past several weeks, India's ambassador to the US Taranjit Singh Sandhu, along with the diplomats from South Africa, had been meeting US lawmakers and officials regarding the proposal

Topics
Coronavirus Vaccine | Intellectual Property Right

Press Trust of India  |  Washington 

"We appreciate the US administration's announcement today of its support for waiver of IPR for Covid-19 vaccines,” India's ambassador to the US Taranjit Singh Sandhu told PTI on Wednesday. ( Pic Source: Twitter)

India has appreciated the Biden administration's decision to support a proposal moved by it and South Africa to temporarily waive some Trade-Related Aspects of Intellectual Property Rights (TRIPS) rules amid the coronavirus pandemic.

For the past several weeks, India's Ambassador to the US Taranjit Singh Sandhu, along with the diplomats from South Africa, had been meeting US lawmakers and officials regarding the proposal.

"We appreciate the US administration's announcement today of its support for waiver of IPR for COVID-19 vaccines, Sandhu told PTI on Wednesday.

Making the announcement, US Trade Representative Katherine Tai said this is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures.

"The (Biden) administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines, Tai said in a major policy announcement.

A majority of Democratic Congressmen had written to President urging him to back the proposal so that vaccines can be made accessible and affordable.

"We also thank the large number of US Senators and Congresspersons who expressed their support. We will continue to work with all stakeholders in the US to collectively fight the global pandemic including through equitable distribution of affordable vaccines for global public health at this critical juncture, Sandhu said in response to a question.

In the past few months, the Indian Embassy had made a focused outreach on the need for equitable access to COVID-19 vaccines in the developing world.

The embassy methodically reached out to the members of the House and Senate. This was reflected in the series of letters that the US lawmakers wrote to President Biden in support.

In recent months, Sandhu has spoken on this issue to Senators Ed Markey and Raphael Warnock; Congresswoman Katherine Clark, Assistant Speaker; Congressman Gregory Meeks, Chair of House Foreign Affairs Committee; Congresswoman Pramila Jayapal, Chair of the Progressive Caucus; Congresswoman Jan Schakowsky and Congressman Ro Khanna.

A joint outreach was also undertaken with the South African Embassy in Washington DC and together, the two envoys had underscored the importance of the issue with Congresswoman Karen Bass, Chair House Foreign Affairs Subcommittee on Africa and Global Health.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Thu, May 06 2021. 08:15 IST
RECOMMENDED FOR YOU